These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 23915385)

  • 1. CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients.
    Pieper J; Herrath J; Raghavan S; Muhammad K; Vollenhoven Rv; Malmström V
    BMC Immunol; 2013 Aug; 14():34. PubMed ID: 23915385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production.
    Cutolo M; Soldano S; Montagna P; Sulli A; Seriolo B; Villaggio B; Triolo P; Clerico P; Felli L; Brizzolara R
    Arthritis Res Ther; 2009; 11(6):R176. PubMed ID: 19930661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.
    Picchianti Diamanti A; Rosado MM; Scarsella M; Germano V; Giorda E; Cascioli S; Laganà B; D'Amelio R; Carsetti R
    Clin Exp Immunol; 2014 Sep; 177(3):630-40. PubMed ID: 24773026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and -negative rheumatoid arthritis patients.
    Gómez-Puerta JA; Celis R; Hernández MV; Ruiz-Esquide V; Ramírez J; Haro I; Cañete JD; Sanmartí R
    Arthritis Res Ther; 2013 Nov; 15(6):R182. PubMed ID: 24485167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis.
    Paulissen SM; van Hamburg JP; Davelaar N; Vroman H; Hazes JM; de Jong PH; Lubberts E
    Arthritis Res Ther; 2015 Nov; 17():344. PubMed ID: 26617177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
    Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V
    Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis.
    Scarsi M; Paolini L; Ricotta D; Pedrini A; Piantoni S; Caimi L; Tincani A; Airò P
    J Rheumatol; 2014 Apr; 41(4):666-72. PubMed ID: 24584924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis.
    Orr C; Najm A; Biniecka M; McGarry T; Ng CT; Young F; Fearon U; Veale DJ
    Arthritis Rheumatol; 2017 Nov; 69(11):2114-2123. PubMed ID: 28732135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation-Lessons From Rheumatoid Arthritis.
    Chemin K; Gerstner C; Malmström V
    Front Immunol; 2019; 10():353. PubMed ID: 30915067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
    Hensvold AH; Joshua V; Li W; Larkin M; Qureshi F; Israelsson L; Padyukov L; Lundberg K; Defranoux N; Saevarsdottir S; Catrina AI
    Arthritis Res Ther; 2015 Sep; 17(1):239. PubMed ID: 26337028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of abatacept in reducing synovial T cell activation by CD1c myeloid dendritic cells is overruled by the stimulatory effects of T cell-activating cytokines.
    Moret FM; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheumatol; 2015 Mar; 67(3):637-44. PubMed ID: 25469671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
    Markovics A; Ocskó T; Katz RS; Buzás EI; Glant TT; Mikecz K
    PLoS One; 2016; 11(7):e0160284. PubMed ID: 27466816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.
    Humby F; Bombardieri M; Manzo A; Kelly S; Blades MC; Kirkham B; Spencer J; Pitzalis C
    PLoS Med; 2009 Jan; 6(1):e1. PubMed ID: 19143467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis.
    Schuerwegh AJ; Ioan-Facsinay A; Dorjée AL; Roos J; Bajema IM; van der Voort EI; Huizinga TW; Toes RE
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2586-91. PubMed ID: 20133791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept.
    Fiocco U; Sfriso P; Oliviero F; Pagnin E; Scagliori E; Campana C; Dainese S; Cozzi L; Punzi L
    Autoimmun Rev; 2008 Oct; 8(1):76-82. PubMed ID: 18718877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weak CD4+ T-cell responses to citrullinated vimentin in rheumatoid arthritis patients carrying HLA-DR9 alleles.
    Catalán D; Aravena O; Zúñiga R; Silva N; Escobar A; Sabugo F; Wurmann P; Soto L; González R; Alfaro J; Larrondo M; Cuchacovich M; Aguillón JC
    Rheumatol Int; 2012 Jun; 32(6):1819-25. PubMed ID: 21769486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistological analysis of synovium treated with abatacept in rheumatoid arthritis.
    Kanbe K; Chiba J; Nakamura A
    Rheumatol Int; 2013 Jul; 33(7):1883-7. PubMed ID: 22212411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is rheumatoid arthritis an autoimmune disease?
    Chemin K; Klareskog L; Malmström V
    Curr Opin Rheumatol; 2016 Mar; 28(2):181-8. PubMed ID: 26780425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis.
    Fukuyo S; Nakayamada S; Iwata S; Kubo S; Saito K; Tanaka Y
    Clin Exp Rheumatol; 2017; 35(4):562-570. PubMed ID: 28516880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis.
    Álvarez-Quiroga C; Abud-Mendoza C; Doníz-Padilla L; Juárez-Reyes A; Monsiváis-Urenda A; Baranda L; González-Amaro R
    J Clin Immunol; 2011 Aug; 31(4):588-95. PubMed ID: 21487894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.